JUN 28, 2018 11:00 PM PDT

Cannabidiol Transdermal Patch Successfully Prevented Drug Use Relapse in Animal Study

WRITTEN BY: Mauri Brueggeman

A group of researchers in the United States recently published their animal investigation in the journal Neuropsychopharmacology.  Their research focused on the creation and use of cannabidiol (CBD) in the prevention of relapse back to drug use.

CBD is being more closely looked at in recent years as a means for treating drug and/or alcohol addiction.  The symptoms that lead to relapse tend to include behaviors that CBD has been known to mitigate in other conditions including anxiety, depression, compulsivity, and neurological mechanisms that lead to drug seeking.  Additionally, research has shown the neuroprotective benefits of cannabinoids, specifically CBD; theoretically, these benefits positively affect neurodegenerative changes that are usually present in the brain of a drug or alcohol addicted individual.  The authors predicted, “…CBD [would have] therapeutic potential relevant for multiple conditions that underlie relapse risk, including craving induced by drug-related environmental contexts, susceptibility to stress, heightened anxiety and, possible, impaired impulse control.”

The authors administered CBD via a transdermal patch which produced stable and consistent plasma CBD levels in the rats used.  The rats were alcohol or cocaine dependent.

The findings were surprising and promising for future research.  They found that CBD diminished drug seeking behaviors with effects that lasted as late as 5 months after treatment was discontinued. The mechanism for this lasting effect has not been elucidated as of the publication of this article.  CBD was also found to decrease anxiety and stress in the rats.  Lastly, the researchers found that this CBD treatment did not cause tranquillizing effects, nor did it negatively affect motivation for rewards.

While it is well known that animal study results do not necessarily easily translate to human effects, the results inform our body of knowledge surrounding medical marijuana; it substantiates the theories that cannabinoids beyond the psychotropic delta-9-tetrahydrocannabinol (THC), the non-addictive and non-psychoactive compounds rather, could be incredibly effective therapeutically in multiple contexts.

Sources: Neuropsychopharmacology

 

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
MAR 07, 2020
Cannabis Sciences
MAR 07, 2020
Why Cannabis Makes Some Feel Good and Others Paranoid
Whether or not someone enjoys the effects of cannabis tends to depend on how it makes them feel. For example, although f ...
APR 25, 2020
Cannabis Sciences
APR 25, 2020
Researchers Trial Cannabis to Treat COVID-19
Researchers in Israel are investigating the potential for cannabis-derived products to treat patients with COVID-19. So ...
MAY 01, 2020
Cannabis Sciences
MAY 01, 2020
Can Cannabis Give You a Hangover?
Hangovers from alcohol and other substances are well known. However, just like with alcohol, after using cannabis, also ...
JUN 13, 2020
Cannabis Sciences
JUN 13, 2020
CBD Kills Brain Cancer Cells in Petri Dish
Cannabis products are not only popular for their psychoactive effects. An increasing number of companies and researchers ...
JUN 26, 2020
Cannabis Sciences
JUN 26, 2020
Cannabis Smoke Contains 110 Toxic Chemicals
Researchers from the University of Alberta in Canada have found that cannabis smoke contains 110 potentially toxic chemi ...
JUL 01, 2020
Health & Medicine
JUL 01, 2020
Could THC Help Advanced Alzheimer's Symptoms?
More than 5 million Americans are living with Alzheimer's disease (AD) according to the Alzheimer's Organization. When t ...
Loading Comments...